Vaccines, Blood & Biologics
?
-
13th International Paul-Ehrlich-Seminar - Allergen Products for Diagnosis and Therapy: Regulation and Science
Date(s) And Time(s):
Sep 14 2011 8:00AM - Sep 17 2011 5:00PM
Location:
Hyatt Regency Washington on Capitol Hill
400 New Jersey Ave NW
Washington, DC 20001-2097
REGISTRATION IS REQUIRED FOR ALL ATTENDEES
Overview:
SAVE THE DATES!
September 14-17, 2011
FEATURED TOPICS
- Legal Aspects of the Regulation of Allergen Products
- Legal Status and Regulation of Allergen Products in the US
- Regulation of Allergen Products in Europe (including NPPs)
- Current Status and Regulation of Allergen Products in Different Countries
- Standardization and Characterization of Allergen Products
- Update on the FDA/CBER Allergen Standardization Program
- Validation of Major Allergen References and ELISAs – Current State of the BSP 090 Project
- Molecular and Functional Characterization of Natural Allergen Extracts
- Standardization of Major Allergen Measurements and Implications for Assessments of Biologic Potency
- The Potential of Mass Spectrometry as Novel Tool in Standardization of Natural Allergen Extracts
- Methods in Product and Study Design of Effective Allergen Products for Therapy
- Quality by Design
- Primary Endpoints, Validation, Clinical Efficacy of Specific Immunotherapy (SIT) Trials
- Specific Aspects of SIT Trials in Children
- Efficacy Testing of Allergen Mixtures
- Surrogates and Biomarkers for Determining Efficacy
- Multiplex IgE Testing as Tool to Define Study Populations
- Pollen Count Variation Within and Among Regions of North America
- Environmental Exposure Chamber in SIT Clinical Trials
- Statistical Analysis for Demonstrating Efficacy in SIT Trials
- Standardization and Characterization of Modified and Recombinant Allergen Products
- Physicochemical Characterization of Allergoids and Adsorbed Allergoids
- Physicochemical Characterization of Recombinant Allergens and Hypoallergenic variants
- Antibody-based Techniques for Characterization of Allergoids and for Stability Studies of Alum Adsorbed Drug Product
- Immunological Mechanisms of Allergy Immunotherapy
- An Overview of Proposed Mechanisms of SIT
- Mechanisms of Immunotherapy Specific to the Sublingual or Oral Route
- Oral Immunotherapy for Food Allergy
- Th2 heterogeneity: Do specific Th2 Subpopulations Alternatively Drive Allergy vs. Tolerance
- Use of Trichuris suis ova (TSO) Therapy for the Treatment
- Immunotherapy with Purified Allergen Components
- Current Status of Subcutaneous and Sublingual Immunotherapy with Recombinant Allergens
- Recombinant Allergens for SIT of Mite Allergy
- Recombinant Allergens for SIT of Cat Allergy
- Novel Approaches of Immunotherapy for Food Allergy
- Targeting Antibody Receptors as an Approach Towards Immunotherapy
- Extrinsic Adjuvants in the Use of Allergen Immunotherapy
- Aluminum Hydroxide: Mechanism of Action and Safety Assessment
- Toll Like Receptor Ligands as Adjuvants
- Adjuvants and Vector Systems for the Sublingual Route
- Immunomodulatory Properties of Allergens
- Inherent Adjuvant Biological Properties of Natural Allergens
- Inherent Adjuvant Structural Properties of Natural Allergens
- State-of-the-Art Immunotherapy in Different Allergic Diseases
- Sublingual Route (SLIT)—Overview of American Experience
- SLIT for Allergic Rhinitis in the United States
- The Role of Subcutaneous Immunotherapy (SCIT) and SLIT in Rhinoconjunctivities across Europe
- SIT for the Treatment of Atopic Dermatitis
- SIT for the Treatment of Asthma
Target Audience:
Professionals, researchers, academia, regulatory affairs, contract research organizations, and clinicians focused in standardization,vdiagnosis and clinical immunology for allergen products.
Event Code:
11018
Contact Information:
Constance Burnett, Program Developer
Telephone 215.293.5800
Fax 215.442.6199
Email ConstanceBurnett@diahome.org
or
JoAnn Boileau, Program Manager
Telephone 215.442.6175
Fax 215.442.6199
Email JoAnn.Boileau@diahome.org
-
-
